BGEN awarded small molecule production facility contract

BGEN awarded small molecule production facility contract

Almac Sciences has appointed BGEN as the principal contractor for its new molecule production facility in Craigavon, Northern Ireland. 

 

BGEN is responsible for the development of the new building and the mechanical, structural, electrical, and instrumentation components of the facility. This includes the installation of four reactors, two isolation trains and ancillary equipment.

 

BGEN is working in collaboration with principal designers, the DPS Group, and BES – part of the BGEN group of companies – responsible for the facility’s HVAC, civil and architectural aspects. 

 

Ian Humphries, Director at BGEN, says, “BGEN is delighted to have secured the award of this important contract with Almac. It reinforces our experience in Active Pharmaceutical Ingredient (API) facilities and uses our group capabilities to enable in-house seamless delivery of the overall construction scope. The award was secured in part by BGEN’s experience and expertise in delivering successful projects using integrated project delivery (IPD) techniques.”

 

Almac Sciences’ GMP Manufacturing Plant was constructed in 1997. This current expansion project will bolster the company’s API production capabilities. 

 

To read more about BGEN, click here.

You May Also Like

Street lamps

Ledvance launches street lamps for retrofit solutions

Ledvance has launched a new range of OSRAM NAV LED retrofit lamps to provide ...

Scheme enables workplaces to climb the safety ladder

Scheme enables workplaces to climb the safety ladder Workplaces across all industries are being ...

Daikin UK Future Thinking seminars to go ‘beyond the buzz’ of BIM

Daikin UK Future Thinking seminars to go ‘beyond the buzz’ of BIM Daikin UK ...